Viagra relaxes muscles found in the walls of blood vessels and increases blood flow to particular areas of the body. Viagra is used to treat erectile dysfunction (impotence) in men. Another brand of sildenafil is Revatio, which is used to treat pulmonary arterial hypertension and improve exercise capacity...
VIAGRA is indicated for the treatment of erectile dysfunction. For most patients, the recommended dose is 50 mg taken, as needed, approximately 1 hour before sexual activity. However, VIAGRA may be taken anywhere from 30 minutes to 4 hours before sexual activity. The maximum recommended dosing frequency...
View more FAQ
Priligy FDA Approval Status Priligy (dapoxetine) is a short-acting selective serotonin reuptake inhibitor (SSRI) under review for the treatment of premature ejaculation. Development timeline for Priligy Date Article Oct 26, 2005 ALZA Corporation Receives Letter From FDA on Dapoxetine Application...
Cialis (tadalafil) increase increases blood flow to a certain area of the body and is used to treat ...
Adcirca is used to treat pulmonary arterial hypertension. Learn about side effects, interactions ...
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Levitra relaxes muscles and increases blood flow to particular areas of the body and is used to ...
Revatio (sildenafil) is used to treat pulmonary arterial hypertension. Includes Revatio side ...
Caverject is used for erectile dysfunction
Edex is used for erectile dysfunction
Muse is used for erectile dysfunction
Vardenafil is used for erectile dysfunction
Alprostadil is used for erectile dysfunction, patent ductus arteriosus
Dapoxetine (International) Scheme Rec.INN ATC (Anatomical Therapeutic Chemical Classification) G04BX14 CAS registry number (Chemical Abstracts Service) 0119356-77-3 Chemical Formula C21-H23-N-O Molecular Weight 305 Therapeutic Categories Serotonin reuptake inhibitor Treatment of premature...
Lejam 30mg (International) Lejam 30mg may be available in the countries listed below. Ingredient matches for Lejam 30mg Dapoxetine Dapoxetine hydrochloride (a derivative of Dapoxetine) is reported as an ingredient of Lejam 30mg in the following countries: Oman Further information Search...
Lejam 60mg (International) Lejam 60mg may be available in the countries listed below. Ingredient matches for Lejam 60mg Dapoxetine Dapoxetine hydrochloride (a derivative of Dapoxetine) is reported as an ingredient of Lejam 60mg in the following countries: Oman Further information Search...
Joypox (International) Joypox may be available in the countries listed below. Ingredient matches for Joypox Dapoxetine Dapoxetine is reported as an ingredient of Joypox in the following countries: Egypt Further information Search international drugs Search Search Examples: bucillamine, flanax...
Tada Plus (International) Tada Plus may be available in the countries listed below. Ingredient matches for Tada Plus Dapoxetine Dapoxetine is reported as an ingredient of Tada Plus in the following countries: Turkey Tadalafil Tadalafil is reported as an ingredient of Tada Plus in the following...
Difare, Ecuador; Ranbaxy, India Cere-T Brisafarma, Peru Circulass Rapid Sherfarma, Peru Corsenile Qualipharm, Peru Dapoksel [+ Dapoxetine] Nobel, Turkey Dapoxil [+ Dapoxetine] Vitalis, Turkey Davigor Swiss & North, Ecuador Daygra Glomed Pharmaceutical Company, Vietnam Defil Labovida, Ecuador Desilmax...
...-Humanity Mepro, Georgia Sinafil Ibn Sina, Bangladesh Snafi Spimaco, Egypt; Spimaco, Oman Tada Eurofarma, Brazil Tada Plus [+ Dapoxetine] Neutec Inhaler, Turkey Tadacip Servimedic, Uruguay Tadal 20 Finadiet, Argentina Tadal 5 Finadiet, Argentina Tadalaciem 20 CIEM, Paraguay Tadalafiil APL Alembic, Estonia...
...(High Risk). This could result in serotonin syndrome. Management: Do not use serotonergic agents (high risk) with dapoxetine or within 7 days of serotonergic agent discontinuation. Do not use dapoxetine within 14 days of monoamine oxidase inhibitor use. Dapoxetine labeling lists this combination as...
...% higher in patients with mild hepatic impairment. The mean AUC was 86% higher and the mean C max was 41% higher in patients with moderate impairment. For palonosetron, the AUC was 33% higher in patients with mild hepatic impairment and 62% higher in patients with moderate impairment; the mean C max was 14...
